お電話でもお問い合わせください
03-5860-2441
Report thumbnail
商品コード LP09144124864EA
出版日 2024/4/19
LP Information
英文110 ページグローバル

鶏マイコプラズマ病の予防と診断のグローバル市場成長展望、2024年〜2030年

Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Growth (Status and Outlook) 2024-2030


Report thumbnail
商品コード LP09144124864EA◆2025年4月版も出版されている時期ですので、お問い合わせ後すぐに確認いたします。
出版日 2024/4/19
LP Information
英文 110 ページグローバル

鶏マイコプラズマ病の予防と診断のグローバル市場成長展望、2024年〜2030年

Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Growth (Status and Outlook) 2024-2030



全体要約

鶏マイコプラズマ病の予防と診断市場について調査・分析を行った市場レポート。
鶏マイコプラズマ病の予防と診断市場は、2023年から2030年にかけて成長が見込まれています。特に、アメリカ、中国、ヨーロッパ市場では、各地域での成長率が注目されています。主要企業には、メルク、セバ、ゾエティス、バイエルインゲルハイム、エランコが含まれ、2023年には市場の大部分を占めています。

市場は、マイコプラズマ・ガリセプティカムとマイコプラズマ・シノバイエに分かれ、オフラインおよびオンライン販売が行われています。地域別の分析により、アメリカ大陸、アジア太平洋、ヨーロッパ、中東・アフリカの各市場の動向が明らかになり、今後の成長機会が示されています。

関連する質問

Merck, Ceva, Zoetis, Boehringer Ingelheim, Elanco, Shandong Huahong Bioengineering Co., Ltd., Jilin Zhengye Biological Products Co., Ltd., Qingdao Yibang Bioengineering Co., Ltd., Shandong Ludu Biotechnology Co., Ltd., Ruipu Biopharmaceutical Co., Ltd.

製品セグメンテーションのトレンド, 地域別市場の成長機会, 主要企業の戦略分析


概要

プロウロキナーゼは、二重鎖ウロキナーゼの単鎖前駆体です。これは主にフィブリンの表面にあるフィブリン溶解蛋白を活性化するため、選択的な血栓溶解効果を持っています。臨床結果は、t-PA、ストレプトキナーゼまたはウロキナーゼと組み合わせたときに相乗効果を示す、安全で効果的な血栓溶解薬であることを示しています。
鶏マイコプラズマ病の予防と診断に関する世界市場規模は、2023年のXX米ドルから2030年のXX米ドルに成長すると予測されています。2024年から2030年にかけて、年平均成長率(CAGR)がXX%の成長が期待されています。
LPI (LP Information)の最新の研究報告書「鶏マイコプラズマ病の予防と診断業界予測」では、過去の売上を考察し、2023年の世界の鶏マイコプラズマ病の予防と診断の総売上をレビューします。2024年から2030年にかけての予測される鶏マイコプラズマ病の予防と診断の売上に関する地域および市場セクター別の包括的な分析を提供します。地域、市場セクターおよびサブセクターごとに分解された鶏マイコプラズマ病の予防と診断の売上について、この報告書は世界の鶏マイコプラズマ病産業の詳細な分析を百万米ドル単位で提供します。
このインサイトレポートは、世界の鶏ミコプラズマ病予防及び診断の状況に関する包括的な分析を提供し、製品セグメンテーション、企業形成、収益、市場シェア、最新の開発およびM&A活動に関する重要なトレンドを強調しています。また、このレポートは、鶏ミコプラズマ病予防及び診断ポートフォリオと能力、市場参入戦略、市場ポジション、地理的展開に焦点を当てながら、主要なグローバル企業の戦略を分析し、加速するグローバルな鶏ミコプラズマ病予防及び診断市場におけるこれらの企業の独自の位置をよりよく理解するためのものです。
このインサイトレポートは、鶏マイコプラズマ病の予防および診断における世界的な展望を形成する主要な市場動向、ドライバー、および影響要因を評価し、タイプ、アプリケーション、地理、そして市場規模によって予測を細分化し、新たな機会のポケットを浮き彫りにします。数百のボトムアップの定性的および定量的市場インプットに基づく透明な方法論を用いたこの研究予測は、鶏マイコプラズマ病の予防および診断における現在の状況と将来の軌道について非常に詳細な見解を提供します。
アメリカ市場における鶏マイコプラズマ病の予防と診断の市場は、2023年のXX米ドルから2030年までにXX米ドルに増加すると推定されており、2024年から2030年までの間にXX%のCAGRを記録する見込みです。
中国の鶏マイコプラズマ病の予防および診断市場は、2023年のXX米ドルから2030年までにXX米ドルに増加すると推定されており、2024年から2030年までの期間でXX%のCAGRを記録する見込みです。
鶏ミコプラズマ病の予防と診断に関するヨーロッパ市場は、2023年のXX米ドルから2030年までにXX米ドルに増加すると推定されており、2024年から2030年までの期間中にXX%の年平均成長率(CAGR)を記録する見込みです。
グローバルな鶏ミコプラズマ病の予防と診断の主要プレーヤーは、メルク、セバ、ゾエティス、バイエル、エランコなどです。収益の観点では、2023年において、世界で最も大きな2社がほぼXX%のシェアを占めました。
このレポートは、製品タイプ、アプリケーション、主要プレーヤー、および主要な地域と国別の鶏マイコプラズマ病の予防と診断市場の包括的な概要、市場シェア、成長機会を提示します。
タイプ別のセグメンテーション
マイコプラズマ・ガリセプティカム
マイコプラズマ・シノバイエス
アプリケーション別のセグメンテーション
オフライン販売
オンライン販売
この報告書では、市場を地域別に分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下にプロフィールされた企業は、一次専門家からの情報収集および企業のカバレッジ、製品ポートフォリオ、市場浸透の分析に基づいて選定されています。
メルク
セバ
ゾエティス
ボーリンガー・イングelハイム
エランコ
山東華弘バイオエンジニアリング株式会社
吉林正业生物制品有限公司
青島易邦生物工学株式会社
山東盧杜生物技術有限公司
瑞普生物医薬株式会社

※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。

目次

  • 1 調査範囲

    • 1.1 市場イントロダクション
    • 1.2 対象年
    • 1.3 調査目的
    • 1.4 市場調査手法
    • 1.5 調査プロセスとデータソース
    • 1.6 経済指標
    • 1.7 通貨
    • 1.8 市場予測における留意事項
  • 2 エグゼクティブサマリー

    • 2.1 世界市場概要
      • 2.1.1 グローバルの鶏マイコプラズマ病の予防と診断市場規模、(2019年~2030年)
      • 2.1.2 鶏マイコプラズマ病の予防と診断市場規模、CAGR(地域別)(2019年 vs 2023年 vs 2030年)
    • 2.2 鶏マイコプラズマ病の予防と診断セグメント、タイプ別
      • 2.2.1 胆汁うっ滞性マイコプラズマ
      • 2.2.2 シノビエ・マイコプラズマ
    • 2.3 鶏マイコプラズマ病の予防と診断市場規模:タイプ別
      • 2.3.1 鶏マイコプラズマ病の予防と診断市場規模、CAGR(タイプ別)(2019年 vs 2023年 vs 2030年)
      • 2.3.2 グローバルの鶏マイコプラズマ病の予防と診断市場規模、市場シェア(タイプ別)(2019年~2024年)
    • 2.4 鶏マイコプラズマ病の予防と診断セグメント、用途別
      • 2.4.1 オフラインセールス
      • 2.4.2 オンライン販売
    • 2.5 鶏マイコプラズマ病の予防と診断市場規模:用途別
      • 2.5.1 鶏マイコプラズマ病の予防と診断市場規模、CAGR(用途別)(2019年 vs 2023年 vs 2030年)
      • 2.5.2 グローバルの鶏マイコプラズマ病の予防と診断市場規模、市場シェア(用途別)(2019年~2024年)
  • 3 鶏マイコプラズマ病の予防と診断市場規模:プレイヤー別

    • 3.1 鶏マイコプラズマ病の予防と診断市場規模、市場シェア(プレイヤー別)
      • 3.1.1 グローバルにおける鶏マイコプラズマ病の予防と診断市場の収益規模、プレイヤー別(2019年~2024年)
      • 3.1.2 グローバルにおける鶏マイコプラズマ病の予防と診断市場の収益シェア、プレイヤー別(2019年~2024年)
    • 3.2 グローバルの鶏マイコプラズマ病の予防と診断市場キープレイヤー拠点および提供製品
    • 3.3 市場集中度分析
      • 3.3.1 競合情勢分析
      • 3.3.2 集中度レシオ(CR3、CR5、CR10)(2022年~2024年)
    • 3.4 新製品・潜在的参入
    • 3.5 M&A、拡大
  • 4 鶏マイコプラズマ病の予防と診断、地域別

    • 4.1 鶏マイコプラズマ病の予防と診断市場規模(地域別)(2019年~2024年)
    • 4.2 アメリカズにおける鶏マイコプラズマ病の予防と診断市場規模成長(2019年〜2024年)
    • 4.3 APACにおける鶏マイコプラズマ病の予防と診断市場規模成長(2019年〜2024年)
    • 4.4 ヨーロッパにおける鶏マイコプラズマ病の予防と診断市場規模成長(2019年〜2024年)
    • 4.5 中東・アフリカにおける鶏マイコプラズマ病の予防と診断市場規模成長(2019年〜2024年)
  • 5 アメリカズ

    • 5.1 アメリカズにおける鶏マイコプラズマ病の予防と診断市場規模、国別(2019年〜2024年)
    • 5.2 アメリカズにおける鶏マイコプラズマ病の予防と診断市場規模、タイプ別(2019年〜2024年)
    • 5.3 アメリカズにおける鶏マイコプラズマ病の予防と診断市場規模、用途別(2019年〜2024年)
    • 5.4 米国
    • 5.5 カナダ
    • 5.6 メキシコ
    • 5.7 ブラジル
  • 6 APAC

    • 6.1 APACにおける鶏マイコプラズマ病の予防と診断市場規模、地域別(2019年〜2024年)
    • 6.2 APACにおける鶏マイコプラズマ病の予防と診断市場規模、タイプ別(2019年〜2024年)
    • 6.3 APACにおける鶏マイコプラズマ病の予防と診断市場規模、用途別(2019年〜2024年)
    • 6.4 中国
    • 6.5 日本
    • 6.6 韓国
    • 6.7 東南アジア
    • 6.8 インド
    • 6.9 オーストラリア
  • 7 ヨーロッパ

    • 7.1 ヨーロッパの鶏マイコプラズマ病の予防と診断 国別(2019年~2024年)
    • 7.2 ヨーロッパにおける鶏マイコプラズマ病の予防と診断市場規模、タイプ別(2019年〜2024年)
    • 7.3 ヨーロッパにおける鶏マイコプラズマ病の予防と診断市場規模、用途別(2019年〜2024年)
    • 7.4 ドイツ
    • 7.5 フランス
    • 7.6 英国
    • 7.7 イタリア
    • 7.8 ロシア
  • 8 中東・アフリカ

    • 8.1 中東・アフリカの鶏マイコプラズマ病の予防と診断 地域別(2019年~2024年)
    • 8.2 中東・アフリカにおける鶏マイコプラズマ病の予防と診断市場規模、タイプ別(2019年〜2024年)
    • 8.3 中東・アフリカにおける鶏マイコプラズマ病の予防と診断市場規模、用途別(2019年〜2024年)
    • 8.4 エジプト
    • 8.5 南アフリカ
    • 8.6 イスラエル
    • 8.7 トルコ
    • 8.8 GCC地域
  • 9 市場ドライバー・課題・トレンド

    • 9.1 市場ドライバー・成長機会
    • 9.2 市場課題・リスク
    • 9.3 業界トレンド
  • 10 グローバルの鶏マイコプラズマ病の予防と診断市場、市場予測

    • 10.1 グローバルの鶏マイコプラズマ病の予防と診断、市場予測(地域別)(2025年~2030年)
      • 10.1.1 グローバルの鶏マイコプラズマ病の予防と診断、市場予測(地域別)(2025年~2030年)
      • 10.1.2 アメリカズの鶏マイコプラズマ病の予防と診断、市場予測
      • 10.1.3 APACの鶏マイコプラズマ病の予防と診断、市場予測
      • 10.1.4 ヨーロッパの鶏マイコプラズマ病の予防と診断、市場予測
      • 10.1.5 中東・アフリカの鶏マイコプラズマ病の予防と診断、市場予測
    • 10.2 アメリカズの鶏マイコプラズマ病の予防と診断、市場予測(国別)(2025年~2030年)
    • 10.3 APACの鶏マイコプラズマ病の予防と診断、市場予測(地域別)(2025年~2030年)
    • 10.4 ヨーロッパの鶏マイコプラズマ病の予防と診断、市場予測(国別)(2025年~2030年)
    • 10.5 中東・アフリカの鶏マイコプラズマ病の予防と診断、市場予測(地域別)(2025年~2030年)
    • 10.6 グローバルの鶏マイコプラズマ病の予防と診断、市場予測(タイプ別)(2025年~2030年)
    • 10.7 グローバルの鶏マイコプラズマ病の予防と診断、市場予測(用途別)(2025年~2030年)
  • 11 キープレイヤー分析

    • 11.1 Merck
      • 11.1.1 Merck:企業情報
      • 11.1.2 Merck:鶏マイコプラズマ病の予防と診断分野の提供製品
      • 11.1.3 Merck:鶏マイコプラズマ病の予防と診断収益・グロスマージンおよび市場シェア(2019年~2024年)
      • 11.1.4 Merck:主要事業概要
      • 11.1.5 Merck:直近の展開
    • 11.2 Ceva
      • 11.2.1 Ceva:企業情報
      • 11.2.2 Ceva:鶏マイコプラズマ病の予防と診断分野の提供製品
      • 11.2.3 Ceva:鶏マイコプラズマ病の予防と診断収益・グロスマージンおよび市場シェア(2019年~2024年)
      • 11.2.4 Ceva:主要事業概要
      • 11.2.5 Ceva:直近の展開
    • 11.3 Zoetis
      • 11.3.1 Zoetis:企業情報
      • 11.3.2 Zoetis:鶏マイコプラズマ病の予防と診断分野の提供製品
      • 11.3.3 Zoetis:鶏マイコプラズマ病の予防と診断収益・グロスマージンおよび市場シェア(2019年~2024年)
      • 11.3.4 Zoetis:主要事業概要
      • 11.3.5 Zoetis:直近の展開
    • 11.4 Boehringer Ingelheim
      • 11.4.1 Boehringer Ingelheim:企業情報
      • 11.4.2 Boehringer Ingelheim:鶏マイコプラズマ病の予防と診断分野の提供製品
      • 11.4.3 Boehringer Ingelheim:鶏マイコプラズマ病の予防と診断収益・グロスマージンおよび市場シェア(2019年~2024年)
      • 11.4.4 Boehringer Ingelheim:主要事業概要
      • 11.4.5 Boehringer Ingelheim:直近の展開
    • 11.5 Elanco
      • 11.5.1 Elanco:企業情報
      • 11.5.2 Elanco:鶏マイコプラズマ病の予防と診断分野の提供製品
      • 11.5.3 Elanco:鶏マイコプラズマ病の予防と診断収益・グロスマージンおよび市場シェア(2019年~2024年)
      • 11.5.4 Elanco:主要事業概要
      • 11.5.5 Elanco:直近の展開
    • 11.6 Shandong Huahong Bioengineering Co\., Ltd
    • 11.7 Jilin Zhengye Biological Products Co\., Ltd
    • 11.8 Qingdao Yibang Bioengineering Co\., Ltd
    • 11.9 Shandong Ludu Biotechnology Co\., Ltd
    • 11.10 Ruipu Biopharmaceutical Co\., Ltd
  • 12 調査の結果・結論

※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”


Description

Prourokinase is the single-chain precursor of double-chain urokinase. It mainly activates fibrinolytic protein on the surface of fibrin, so it has selective thrombolytic effect. Clinical results show that it is a safe and effective thrombolytic drug that has synergistic effects when combined with t-PA, streptokinase or urokinase.
The global Prevention and Diagnosis of Chicken Mycoplasma Disease market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Prevention and Diagnosis of Chicken Mycoplasma Disease Industry Forecast” looks at past sales and reviews total world Prevention and Diagnosis of Chicken Mycoplasma Disease sales in 2023, providing a comprehensive analysis by region and market sector of projected Prevention and Diagnosis of Chicken Mycoplasma Disease sales for 2024 through 2030. With Prevention and Diagnosis of Chicken Mycoplasma Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prevention and Diagnosis of Chicken Mycoplasma Disease industry.
This Insight Report provides a comprehensive analysis of the global Prevention and Diagnosis of Chicken Mycoplasma Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prevention and Diagnosis of Chicken Mycoplasma Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prevention and Diagnosis of Chicken Mycoplasma Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prevention and Diagnosis of Chicken Mycoplasma Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prevention and Diagnosis of Chicken Mycoplasma Disease.
United States market for Prevention and Diagnosis of Chicken Mycoplasma Disease is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Prevention and Diagnosis of Chicken Mycoplasma Disease is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Prevention and Diagnosis of Chicken Mycoplasma Disease is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Prevention and Diagnosis of Chicken Mycoplasma Disease players cover Merck, Ceva, Zoetis, Boehringer Ingelheim and Elanco, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Prevention and Diagnosis of Chicken Mycoplasma Disease market by product type, application, key players and key regions and countries.
Segmentation by type
Mycoplasma Gallisepticum
Mycoplasma Synoviae
Segmentation by application
Offline Sales
Online Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Ceva
Zoetis
Boehringer Ingelheim
Elanco
Shandong Huahong Bioengineering Co., Ltd.
Jilin Zhengye Biological Products Co., Ltd.
Qingdao Yibang Bioengineering Co., Ltd.
Shandong Ludu Biotechnology Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2019-2030
      • 2.1.2 Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size CAGR by Region 2019 VS 2023 VS 2030
    • 2.2 Prevention and Diagnosis of Chicken Mycoplasma Disease Segment by Type
      • 2.2.1 Mycoplasma Gallisepticum
      • 2.2.2 Mycoplasma Synoviae
    • 2.3 Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Type
      • 2.3.1 Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
      • 2.3.2 Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Type (2019-2024)
    • 2.4 Prevention and Diagnosis of Chicken Mycoplasma Disease Segment by Application
      • 2.4.1 Offline Sales
      • 2.4.2 Online Sales
    • 2.5 Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Application
      • 2.5.1 Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
      • 2.5.2 Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Application (2019-2024)
  • 3 Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Player

    • 3.1 Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Players
      • 3.1.1 Global Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue by Players (2019-2024)
      • 3.1.2 Global Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue Market Share by Players (2019-2024)
    • 3.2 Global Prevention and Diagnosis of Chicken Mycoplasma Disease Key Players Head office and Products Offered
    • 3.3 Market Concentration Rate Analysis
      • 3.3.1 Competition Landscape Analysis
      • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    • 3.4 New Products and Potential Entrants
    • 3.5 Mergers & Acquisitions, Expansion
  • 4 Prevention and Diagnosis of Chicken Mycoplasma Disease by Regions

    • 4.1 Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Regions (2019-2024)
    • 4.2 Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth (2019-2024)
    • 4.3 APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth (2019-2024)
    • 4.4 Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth (2019-2024)
    • 4.5 Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth (2019-2024)
  • 5 Americas

    • 5.1 Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Country (2019-2024)
    • 5.2 Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Type (2019-2024)
    • 5.3 Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Application (2019-2024)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Region (2019-2024)
    • 6.2 APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Type (2019-2024)
    • 6.3 APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Application (2019-2024)
    • 6.4 China
    • 6.5 Japan
    • 6.6 Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
  • 7 Europe

    • 7.1 Europe Prevention and Diagnosis of Chicken Mycoplasma Disease by Country (2019-2024)
    • 7.2 Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Type (2019-2024)
    • 7.3 Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Application (2019-2024)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease by Region (2019-2024)
    • 8.2 Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Type (2019-2024)
    • 8.3 Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Application (2019-2024)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast

    • 10.1 Global Prevention and Diagnosis of Chicken Mycoplasma Disease Forecast by Regions (2025-2030)
      • 10.1.1 Global Prevention and Diagnosis of Chicken Mycoplasma Disease Forecast by Regions (2025-2030)
      • 10.1.2 Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Forecast
      • 10.1.3 APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Forecast
      • 10.1.4 Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Forecast
      • 10.1.5 Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Forecast
    • 10.2 Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Forecast by Country (2025-2030)
      • 10.2.1 United States Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.2.2 Canada Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.2.3 Mexico Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.2.4 Brazil Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
    • 10.3 APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Forecast by Region (2025-2030)
      • 10.3.1 China Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.3.2 Japan Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.3.3 Korea Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.3.4 Southeast Asia Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.3.5 India Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.3.6 Australia Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
    • 10.4 Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Forecast by Country (2025-2030)
      • 10.4.1 Germany Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.4.2 France Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.4.3 UK Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.4.4 Italy Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.4.5 Russia Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
    • 10.5 Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Forecast by Region (2025-2030)
      • 10.5.1 Egypt Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.5.2 South Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.5.3 Israel Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.5.4 Turkey Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
      • 10.5.5 GCC Countries Prevention and Diagnosis of Chicken Mycoplasma Disease Market Forecast
    • 10.6 Global Prevention and Diagnosis of Chicken Mycoplasma Disease Forecast by Type (2025-2030)
    • 10.7 Global Prevention and Diagnosis of Chicken Mycoplasma Disease Forecast by Application (2025-2030)
  • 11 Key Players Analysis

    • 11.1 Merck
      • 11.1.1 Merck Company Information
      • 11.1.2 Merck Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered
      • 11.1.3 Merck Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue, Gross Margin and Market Share (2019-2024)
      • 11.1.4 Merck Main Business Overview
      • 11.1.5 Merck Latest Developments
    • 11.2 Ceva
      • 11.2.1 Ceva Company Information
      • 11.2.2 Ceva Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered
      • 11.2.3 Ceva Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue, Gross Margin and Market Share (2019-2024)
      • 11.2.4 Ceva Main Business Overview
      • 11.2.5 Ceva Latest Developments
    • 11.3 Zoetis
      • 11.3.1 Zoetis Company Information
      • 11.3.2 Zoetis Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered
      • 11.3.3 Zoetis Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue, Gross Margin and Market Share (2019-2024)
      • 11.3.4 Zoetis Main Business Overview
      • 11.3.5 Zoetis Latest Developments
    • 11.4 Boehringer Ingelheim
      • 11.4.1 Boehringer Ingelheim Company Information
      • 11.4.2 Boehringer Ingelheim Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered
      • 11.4.3 Boehringer Ingelheim Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue, Gross Margin and Market Share (2019-2024)
      • 11.4.4 Boehringer Ingelheim Main Business Overview
      • 11.4.5 Boehringer Ingelheim Latest Developments
    • 11.5 Elanco
      • 11.5.1 Elanco Company Information
      • 11.5.2 Elanco Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered
      • 11.5.3 Elanco Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue, Gross Margin and Market Share (2019-2024)
      • 11.5.4 Elanco Main Business Overview
      • 11.5.5 Elanco Latest Developments
    • 11.6 Shandong Huahong Bioengineering Co., Ltd.
      • 11.6.1 Shandong Huahong Bioengineering Co., Ltd. Company Information
      • 11.6.2 Shandong Huahong Bioengineering Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered
      • 11.6.3 Shandong Huahong Bioengineering Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue, Gross Margin and Market Share (2019-2024)
      • 11.6.4 Shandong Huahong Bioengineering Co., Ltd. Main Business Overview
      • 11.6.5 Shandong Huahong Bioengineering Co., Ltd. Latest Developments
    • 11.7 Jilin Zhengye Biological Products Co., Ltd.
      • 11.7.1 Jilin Zhengye Biological Products Co., Ltd. Company Information
      • 11.7.2 Jilin Zhengye Biological Products Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered
      • 11.7.3 Jilin Zhengye Biological Products Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue, Gross Margin and Market Share (2019-2024)
      • 11.7.4 Jilin Zhengye Biological Products Co., Ltd. Main Business Overview
      • 11.7.5 Jilin Zhengye Biological Products Co., Ltd. Latest Developments
    • 11.8 Qingdao Yibang Bioengineering Co., Ltd.
      • 11.8.1 Qingdao Yibang Bioengineering Co., Ltd. Company Information
      • 11.8.2 Qingdao Yibang Bioengineering Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered
      • 11.8.3 Qingdao Yibang Bioengineering Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue, Gross Margin and Market Share (2019-2024)
      • 11.8.4 Qingdao Yibang Bioengineering Co., Ltd. Main Business Overview
      • 11.8.5 Qingdao Yibang Bioengineering Co., Ltd. Latest Developments
    • 11.9 Shandong Ludu Biotechnology Co., Ltd.
      • 11.9.1 Shandong Ludu Biotechnology Co., Ltd. Company Information
      • 11.9.2 Shandong Ludu Biotechnology Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered
      • 11.9.3 Shandong Ludu Biotechnology Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue, Gross Margin and Market Share (2019-2024)
      • 11.9.4 Shandong Ludu Biotechnology Co., Ltd. Main Business Overview
      • 11.9.5 Shandong Ludu Biotechnology Co., Ltd. Latest Developments
    • 11.10 Ruipu Biopharmaceutical Co., Ltd.
      • 11.10.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
      • 11.10.2 Ruipu Biopharmaceutical Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered
      • 11.10.3 Ruipu Biopharmaceutical Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue, Gross Margin and Market Share (2019-2024)
      • 11.10.4 Ruipu Biopharmaceutical Co., Ltd. Main Business Overview
      • 11.10.5 Ruipu Biopharmaceutical Co., Ltd. Latest Developments
  • 12 Research Findings and Conclusion

List of Tables Table 1. Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions) Table 2. Major Players of Mycoplasma Gallisepticum Table 3. Major Players of Mycoplasma Synoviae Table 4. Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions) Table 5. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Type (2019-2024) & ($ Millions) Table 6. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Type (2019-2024) Table 7. Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions) Table 8. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Application (2019-2024) & ($ Millions) Table 9. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Application (2019-2024) Table 10. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue by Players (2019-2024) & ($ Millions) Table 11. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue Market Share by Player (2019-2024) Table 12. Prevention and Diagnosis of Chicken Mycoplasma Disease Key Players Head office and Products Offered Table 13. Prevention and Diagnosis of Chicken Mycoplasma Disease Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Regions 2019-2024 & ($ Millions) Table 17. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Regions (2019-2024) Table 18. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue by Country/Region (2019-2024) & ($ millions) Table 19. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue Market Share by Country/Region (2019-2024) Table 20. Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Country (2019-2024) & ($ Millions) Table 21. Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Country (2019-2024) Table 22. Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Type (2019-2024) & ($ Millions) Table 23. Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Type (2019-2024) Table 24. Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Application (2019-2024) & ($ Millions) Table 25. Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Application (2019-2024) Table 26. APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Region (2019-2024) & ($ Millions) Table 27. APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Region (2019-2024) Table 28. APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Type (2019-2024) & ($ Millions) Table 29. APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Type (2019-2024) Table 30. APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Application (2019-2024) & ($ Millions) Table 31. APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Application (2019-2024) Table 32. Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Country (2019-2024) & ($ Millions) Table 33. Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Country (2019-2024) Table 34. Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Type (2019-2024) & ($ Millions) Table 35. Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Type (2019-2024) Table 36. Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Application (2019-2024) & ($ Millions) Table 37. Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Application (2019-2024) Table 38. Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Region (2019-2024) & ($ Millions) Table 39. Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Region (2019-2024) Table 40. Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Type (2019-2024) & ($ Millions) Table 41. Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Type (2019-2024) Table 42. Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size by Application (2019-2024) & ($ Millions) Table 43. Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Application (2019-2024) Table 44. Key Market Drivers & Growth Opportunities of Prevention and Diagnosis of Chicken Mycoplasma Disease Table 45. Key Market Challenges & Risks of Prevention and Diagnosis of Chicken Mycoplasma Disease Table 46. Key Industry Trends of Prevention and Diagnosis of Chicken Mycoplasma Disease Table 47. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Forecast by Regions (2025-2030) & ($ Millions) Table 48. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share Forecast by Regions (2025-2030) Table 49. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Forecast by Type (2025-2030) & ($ Millions) Table 50. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Forecast by Application (2025-2030) & ($ Millions) Table 51. Merck Details, Company Type, Prevention and Diagnosis of Chicken Mycoplasma Disease Area Served and Its Competitors Table 52. Merck Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered Table 53. Merck Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 54. Merck Main Business Table 55. Merck Latest Developments Table 56. Ceva Details, Company Type, Prevention and Diagnosis of Chicken Mycoplasma Disease Area Served and Its Competitors Table 57. Ceva Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered Table 58. Ceva Main Business Table 59. Ceva Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 60. Ceva Latest Developments Table 61. Zoetis Details, Company Type, Prevention and Diagnosis of Chicken Mycoplasma Disease Area Served and Its Competitors Table 62. Zoetis Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered Table 63. Zoetis Main Business Table 64. Zoetis Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 65. Zoetis Latest Developments Table 66. Boehringer Ingelheim Details, Company Type, Prevention and Diagnosis of Chicken Mycoplasma Disease Area Served and Its Competitors Table 67. Boehringer Ingelheim Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered Table 68. Boehringer Ingelheim Main Business Table 69. Boehringer Ingelheim Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 70. Boehringer Ingelheim Latest Developments Table 71. Elanco Details, Company Type, Prevention and Diagnosis of Chicken Mycoplasma Disease Area Served and Its Competitors Table 72. Elanco Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered Table 73. Elanco Main Business Table 74. Elanco Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 75. Elanco Latest Developments Table 76. Shandong Huahong Bioengineering Co., Ltd. Details, Company Type, Prevention and Diagnosis of Chicken Mycoplasma Disease Area Served and Its Competitors Table 77. Shandong Huahong Bioengineering Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered Table 78. Shandong Huahong Bioengineering Co., Ltd. Main Business Table 79. Shandong Huahong Bioengineering Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 80. Shandong Huahong Bioengineering Co., Ltd. Latest Developments Table 81. Jilin Zhengye Biological Products Co., Ltd. Details, Company Type, Prevention and Diagnosis of Chicken Mycoplasma Disease Area Served and Its Competitors Table 82. Jilin Zhengye Biological Products Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered Table 83. Jilin Zhengye Biological Products Co., Ltd. Main Business Table 84. Jilin Zhengye Biological Products Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 85. Jilin Zhengye Biological Products Co., Ltd. Latest Developments Table 86. Qingdao Yibang Bioengineering Co., Ltd. Details, Company Type, Prevention and Diagnosis of Chicken Mycoplasma Disease Area Served and Its Competitors Table 87. Qingdao Yibang Bioengineering Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered Table 88. Qingdao Yibang Bioengineering Co., Ltd. Main Business Table 89. Qingdao Yibang Bioengineering Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 90. Qingdao Yibang Bioengineering Co., Ltd. Latest Developments Table 91. Shandong Ludu Biotechnology Co., Ltd. Details, Company Type, Prevention and Diagnosis of Chicken Mycoplasma Disease Area Served and Its Competitors Table 92. Shandong Ludu Biotechnology Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered Table 93. Shandong Ludu Biotechnology Co., Ltd. Main Business Table 94. Shandong Ludu Biotechnology Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 95. Shandong Ludu Biotechnology Co., Ltd. Latest Developments Table 96. Ruipu Biopharmaceutical Co., Ltd. Details, Company Type, Prevention and Diagnosis of Chicken Mycoplasma Disease Area Served and Its Competitors Table 97. Ruipu Biopharmaceutical Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Product Offered Table 98. Ruipu Biopharmaceutical Co., Ltd. Main Business Table 99. Ruipu Biopharmaceutical Co., Ltd. Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 100. Ruipu Biopharmaceutical Co., Ltd. Latest Developments List of Figures Figure 1. Prevention and Diagnosis of Chicken Mycoplasma Disease Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth Rate 2019-2030 ($ Millions) Figure 6. Prevention and Diagnosis of Chicken Mycoplasma Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Prevention and Diagnosis of Chicken Mycoplasma Disease Sales Market Share by Country/Region (2023) Figure 8. Prevention and Diagnosis of Chicken Mycoplasma Disease Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Type in 2023 Figure 10. Prevention and Diagnosis of Chicken Mycoplasma Disease in Offline Sales Figure 11. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market: Offline Sales (2019-2024) & ($ Millions) Figure 12. Prevention and Diagnosis of Chicken Mycoplasma Disease in Online Sales Figure 13. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market: Online Sales (2019-2024) & ($ Millions) Figure 14. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Application in 2023 Figure 15. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Revenue Market Share by Player in 2023 Figure 16. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Regions (2019-2024) Figure 17. Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2019-2024 ($ Millions) Figure 18. APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2019-2024 ($ Millions) Figure 19. Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2019-2024 ($ Millions) Figure 20. Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2019-2024 ($ Millions) Figure 21. Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Value Market Share by Country in 2023 Figure 22. United States Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 23. Canada Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 24. Mexico Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 25. Brazil Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 26. APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Region in 2023 Figure 27. APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Type in 2023 Figure 28. APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Application in 2023 Figure 29. China Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 30. Japan Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 31. Korea Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 32. Southeast Asia Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 33. India Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 34. Australia Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 35. Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Country in 2023 Figure 36. Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Type (2019-2024) Figure 37. Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Application (2019-2024) Figure 38. Germany Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 39. France Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 40. UK Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 41. Italy Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 42. Russia Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 43. Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Region (2019-2024) Figure 44. Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Type (2019-2024) Figure 45. Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share by Application (2019-2024) Figure 46. Egypt Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 47. South Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 48. Israel Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 49. Turkey Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 50. GCC Country Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Growth 2019-2024 ($ Millions) Figure 51. Americas Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 52. APAC Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 53. Europe Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 54. Middle East & Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 55. United States Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 56. Canada Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 57. Mexico Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 58. Brazil Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 59. China Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 60. Japan Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 61. Korea Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 62. Southeast Asia Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 63. India Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 64. Australia Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 65. Germany Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 66. France Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 67. UK Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 68. Italy Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 69. Russia Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 70. Spain Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 71. Egypt Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 72. South Africa Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 73. Israel Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 74. Turkey Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 75. GCC Countries Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size 2025-2030 ($ Millions) Figure 76. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share Forecast by Type (2025-2030) Figure 77. Global Prevention and Diagnosis of Chicken Mycoplasma Disease Market Size Market Share Forecast by Application (2025-2030)

価格:USD 3,660
543,218もしくは部分購入
適用レート
1 USD = 148.42
※稀に出版元により価格が改定されている場合がございます。
contact
© 2023 ShareFair Inc.